Compass Therapeutics Stock Forecast

CMPX's stock price has decreased by -84.21% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 15 analysts polled by S&P Global, Compass Therapeutics stock has a consensus rating of "Buy" and an average price target of $5.26. The average 1-year stock price forecast is 580.28% higher than the current stock price, while the lowest is $0.90 (+16.31%) and the highest is $12 (+1,450.79%).

Price Target: $5.26 (+580.28%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$0.90	$5.26	$4.00	$12
Change	+16.31%	+580.28%	+416.93%	+1450.8%

Analyst Ratings

The average analyst rating for Compass Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26	Nov '26
Strong Buy	11	12	12	10	10	10
Buy	2	2	2	2	2	2
Hold	1	1	1	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	14	15	15	15	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Schmidt Guggenheim	Guggenheim	Buy Maintains $4	Buy	Maintains	$4	+416.93%	Nov 10, 2026
Stephen Willey Stifel Nicolaus	Stifel Nicolaus	Buy Reiterates $6	Buy	Reiterates	$6	+675.39%	Nov 10, 2026
John Newman Canaccord Genuity	Canaccord Genuity	Buy Maintains $7	Buy	Maintains	$7	+804.63%	Nov 10, 2026
Joseph Pantginis H.C. Wainwright	H.C. Wainwright	Buy Maintains $12	Buy	Maintains	$12	+1,450.79%	Nov 9, 2026
Biren Amin Piper Sandler	Piper Sandler	Buy Maintains $6	Buy	Maintains	$6	+675.39%	Oct 26, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

6.51M

EPS This Year

-0.48

from -0.42

EPS Next Year

-0.55

from -0.48

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	850.00K	-	-
Gross Profit	-	-	-	850.00K	-	-
Gross Margin	-	-	-	100.00%	-	85.00%
Operating Income	-31.26M	-41.66M	-50.36M	-56.63M	-72.84M	-105.67M
Net Income	-82.18M	-39.23M	-42.49M	-49.38M	-66.49M	-97.21M
EPS	-	-	-	-	-0.42	-0.48
Free Cash Flow	-	-	-	-	-49.17M	-95.00M
No. Analysts	-	-	-	-	-	14

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.44
Avg	-0.48
Low	-0.52

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-